Online Program Home
My Program

Abstract Details

Activity Number: 704
Type: Contributed
Date/Time: Thursday, August 4, 2016 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #318900
Title: A Class of Semiparametric Models in Analysis of Adverse Events in Drug Safety
Author(s): Richard Entsuah*
Companies: Merck
Keywords: Longitudinal ; Adverse Events
Abstract:

In the area of pharmaceutical drug safety, one of the primary goals in analysis of adverse events (AEs) is to detect any signal of a difference between the treatment and control groups. Traditionally, Crude Incidence Rate, Chi-square Test or Fisher's Exact Test, and Miettinen & Nurminen are the useful methods in analysis of single AE data depending on what level of importance it belongs to, such as Tier 1, Tier 2, or Tier 3. The occurrence of AEs is complicated. Simple measurement of AE data without enough information about duration, severity, or recurrent events, the estimation and inference could be biased. Moreover, multiple AEs within the same System Organ Class (SOC) are usually correlated with each other. So analysis of single AE over simplifies comparison among treatment arms in drug safety. In this presentation, we would like to propose a new class of distribution-free approaches to address the effects of duration, severity, and recurrence of AE data by using a new measurement within certain specified class.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association